Connect with us
The Catalan pharmaceutical company Almirall earned €4.3 million in 2022 and surpassed the losses of €40.9 million it had in 2021. The normalized net result, which...
Once this round is completed, Mikrobiomik plans to initiate a new financing round with the aim of raising €6 million, in which it plans to include...
Boehringer Ingelheim reached a sales figure of €24.1 billion in 2022, which translates into a year-on-year rise of 10.5%. In 2022, the Spanish subsidiary registered an...
Prim aims to achieve sales of €305 million by 2025. The company founded in 1870 expects that by that date 25% of its business will come...
Galenicum Axium, a subsidiary that focuses on the development of licenses and distribution of medicines for other companies and is one of the company's main sources...
Oniria Therapeutics is a company dedicated to the development of precision drugs in the preclinical stage focused on the elimination of persistent tumor cells, which are...
In 2022, the company's results stood at €15.6 million, which translates into a rise of 47.2% compared to the previous year. However, in the same period,...
Grifols has lost around 70% of its market value since the start of the pandemic. In the eyes of investors, its main burdens are debt, which...
Vitro works mainly with public health, which represents between 80% and 85% of its business, and with large private chains. The biotech company has grown to...
The diagnostics sector has the highest expected growth rate until 2030. The report highlights the need for smart financing in order to achieve efficient investment in...
 |
|
 |  |
 |
|